Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Publikationen

Suchbegriffe: CISPLATIN, . Treffer: 101

2020

Fischer, S; Tandstad, T; Cohn-Cedermark, G; Thibault, C; Vincenzi, B; Klingbiel, D; Albany, C; Necchi, A; Terbuch, A; Lorch, A; Aparicio, J; Heidenreich, A; Hentrich, M; Wheater, M; Langberg, CW; Ståhl, O; Fankhauser, CD; Hamid, AA; Koutsoukos, K; Shamash, J; White, J; Bokemeyer, C; Beyer, J; Gillessen, S; Global Germ-Cell Cancer Group Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I Nonseminoma.
J Clin Oncol. 2019; JCO1901876-JCO1901876. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Klöckl, MC; Kasparek, AK; Riedl, JM; Moik, F; Mollnar, S; Stotz, M; Szkandera, J; Terbuch, A; Gerger, A; Niedrist, T; Pichler, M; Bauernhofer, T; Schilcher, G; Zitta, S; Rosenkranz, AR; Friedl, C; Stöger, H; Posch, F Estimation versus measurement of the glomerular filtration rate for kidney function assessment in patients with cancer undergoing cisplatin-based chemotherapy.
Sci Rep. 2020; 10(1): 11219-11219. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Seidl, C; Panzitt, K; Bertsch, A; Brcic, L; Schein, S; Mack, M; Leithner, K; Prinz, F; Olschewski, H; Kornmueller, K; Hrzenjak, A MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2.
Cancer Lett. 2020; 469: 266-276.
Web of Science PubMed FullText FullText_MUG

 

2018

Dietz, A; Wichmann, G; Kuhnt, T; Pfreundner, L; Hagen, R; Scheich, M; Kölbl, O; Hautmann, MG; Strutz, J; Schreiber, F; Bockmühl, U; Schilling, V; Feyer, P; de Wit, M; Maschmeyer, G; Jungehülsing, M; Schroeder, U; Wollenberg, B; Sittel, C; Münter, M; Lenarz, T; Klussmann, JP; Guntinas-Lichius, O; Rudack, C; Eich, HT; Foerg, T; Preyer, S; Westhofen, M; Welkoborsky, HJ; Esser, D; Thurnher, D; Remmert, S; Sudhoff, H; Görner, M; Bünzel, J; Budach, V; Held, S; Knödler, M; Lordick, F; Wiegand, S; Vogel, K; Boehm, A; Flentje, M; Keilholz, U Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II.
Ann Oncol. 2018; 29(10): 2105-2114. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Frille, A; Leithner, K; Olschewski, A; Olschewski, H; Wohlkönig, C; Hrzenjak, A No erythropoietin-induced growth is observed in non-small cell lung cancer cells.
Int J Oncol. 2018; 52(2): 518-526.
Web of Science PubMed FullText FullText_MUG

 

Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Fuchs, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Bartsch, R; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
BMC CANCER. 2018; 18(1): 1074-1074. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Terbuch, A; Posch, F; Partl, R; Zurl, B; Bauernhofer, T; Pichler, M; Szkandera, J; Hutterer, GC; Pummer, K; Kapp, KS; Stöger, H; Gerger, A; Stotz, M Risk stratification for febrile neutropenia in patients with testicular germ cell tumors.
Cancer Med. 2018; 7(2):508-514 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2017

Barac, A; Mitulovic, G; Hallström, S; Zehetmayer, S; Grasl, MC; Erovic, BM Impact of combined treatment with nimesulide and cisplatin on oral carcinoma cells.
Onco Targets Ther. 2017; 10(6):3607-3616 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Enzenhofer, E; Kadletz, L; Stanisz, I; Kotowski, U; Seemann, R; Schmid, R; Thurnher, D; Heiduschka, G Effect of the histone deacetylase inhibitor resminostat on head and neck squamous cell carcinoma cell lines.
Head Neck. 2017; 39(5):900-907
Web of Science PubMed FullText FullText_MUG

 

Fadejeva, I; Olschewski, H; Hrzenjak, A MicroRNAs as regulators of cisplatin-resistance in non-small cell lung carcinomas.
Oncotarget. 2017; 8(70):115754-115773 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ferrari, S; Bielack, SS; Smeland, S; Longhi, A; Egerer, G; Sundby Hall, K; Donati, D; Kevric, M; Brosjö, O; Comandone, A; Werner, M; Monge, O; Palmerini, E; Berdel, WE; Bjerkehagen, B; Paioli, A; Lorenzen, S; Eriksson, M; Gambarotti, M; Tunn, PU; Jebsen, NL; Cesari, M; von Kalle, T; Ferraresi, V; Schwarz, R; Bertulli, R; Kasparek, AK; Grignani, G; Krasniqi, F; Sorg, B; Hecker-Nolting, S; Picci, P; Reichardt, P EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcoma.
Tumori. 2017; 104(1):30-36
Web of Science PubMed FullText FullText_MUG

 

Katanić, J; Matić, S; Pferschy-Wenzig, EM; Kretschmer, N; Boroja, T; Mihailović, V; Stanković, V; Stanković, N; Mladenović, M; Stanić, S; Mihailović, M; Bauer, R Filipendula ulmaria extracts attenuate cisplatin-induced liver and kidney oxidative stress in rats: In vivo investigation and LC-MS analysis.
Food Chem Toxicol. 2017; 99(2):86-102
Web of Science PubMed FullText FullText_MUG

 

Kotowski, U; Heiduschka, G; Kadletz, L; Fahim, T; Seemann, R; Schmid, R; Schneider, S; Mitterbauer, A; Thurnher, D Effect of thymoquinone on head and neck squamous cell carcinoma cells in vitro: Synergism with radiation.
Oncol Lett. 2017; 14(1):1147-1151 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kotowski, U; Kadletz, L; Schneider, S; Foki, E; Schmid, R; Seemann, R; Thurnher, D; Heiduschka, G 6-shogaol induces apoptosis and enhances radiosensitivity in head and neck squamous cell carcinoma cell lines.
Phytother Res. 2017;
Web of Science PubMed FullText FullText_MUG

 

Lill, C; Bachtiary, B; Selzer, E; Mittlboeck, M; Thurnher, D A 5‑year update of patients with HPV positive versus negative oropharyngeal cancer after radiochemotherapy in Austria.
Wien Klin Wochenschr. 2017; 129(11-12):398-403 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Longhi, A; Bielack, SS; Grimer, R; Whelan, J; Windhager, R; Leithner, A; Gronchi, A; Biau, D; Jutte, P; Krieg, AH; Klenke, FM; Grignani, G; Donati, DM; Capanna, R; Casanova, J; Gerrand, C; Bisogno, G; Hecker-Nolting, S; De Lisa, M; D'Ambrosio, L; Willegger, M; Scoccianti, G; Ferrari, S Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients.
Eur J Cancer. 2017; 74(1):9-16 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Mairinger, FD; Vollbrecht, C; Flom, E; Christoph, DC; Schmid, KW; Kollmeier, J; Popper, HH; Mairinger, T; Walter, RFH Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma.
Oncotarget. 2017; 8(23):37502-37510 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Račkauskas, R; Zhou, D; Ūselis, S; Strupas, K; Herr, I; Schemmer, P Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins.
Oncol Rep. 2017; 37(6):3660-3666 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Tiran, V; Lindenmann, J; Brcic, L; Heitzer, E; Stanzer, S; Tabrizi-Wizsy, NG; Stacher, E; Stoeger, H; Popper, HH; Balic, M; Dandachi, N Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.
Sci Rep. 2017; 7(1):10040-10040 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Ugurel, S; Loquai, C; Terheyden, P; Schadendorf, D; Richtig, E; Utikal, J; Gutzmer, R; Rass, K; Sunderkotter, C; Stein, A; Fluck, M; Kaatz, M; Trefzer, U; Kahler, K; Stadler, R; Berking, C; Holler, C; Kerschke, L; Edler, L; Kopp-Schneider, A; Becker, JC Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial
ONCOTARGET. 2017; 8(44): 76029-76043. [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Brambilla, E; Le Teuff, G; Marguet, S; Lantuejoul, S; Dunant, A; Graziano, S; Pirker, R; Douillard, JY; Le Chevalier, T; Filipits, M; Rosell, R; Kratzke, R; Popper, H; Soria, JC; Shepherd, FA; Seymour, L; Tsao, MS Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non-Small-Cell Lung Cancer.
J CLIN ONCOL. 2016; 34(11): 1223-1230. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Czink, E; Heining, C; Weber, TF; Lasitschka, F; Schemmer, P; Schirmacher, P; Weiss, KH; Glimm, H; Brors, B; Weichert, W; Jäger, D; Fröhling, S; Springfeld, C [Durable remission under dual HER2 blockade with Trastuzumab and Pertuzumab in a patient with metastatic gallbladder cancer].
Z Gastroenterol. 2016; 54(5):426-430
Web of Science PubMed FullText FullText_MUG

 

Kadletz, L; Bigenzahn, J; Thurnher, D; Stanisz, I; Erovic, BM; Schneider, S; Schmid, R; Seemann, R; Birner, P; Heiduschka, G Evaluation of Polo-like kinase 1 as a potential therapeutic target in Merkel cell carcinoma.
Head Neck. 2016; 38 Suppl 1(8):E1918-E1925
Web of Science PubMed FullText FullText_MUG

 

Schneider, S; Thurnher, D; Kadletz, L; Seemann, R; Brunner, M; Kotowski, U; Schmid, R; Lill, C; Heiduschka, G Effects of neratinib and combination with irradiation and chemotherapy in head and neck cancer cells.
Oral Dis. 2016; 22(8):797-804
Web of Science PubMed FullText FullText_MUG

 

Willmes, C; Kumar, R; Becker, JC; Fried, I; Rachakonda, PS; Poppe, LM; Hesbacher, S; Schadendorf, D; Sucker, A; Schrama, D; Ugurel, S SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma.
Oncotarget. 2016; 7(9): 10117-10132. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Fischer, C; Leithner, K; Wohlkoenig, C; Quehenberger, F; Bertsch, A; Olschewski, A; Olschewski, H; Hrzenjak, A Panobinostat reduces hypoxia-induced cisplatin resistance of non-small cell lung carcinoma cells via HIF-1α destabilization.
Mol Cancer. 2015; 14(8):4-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Haymerle, G; Thurnher, D; Kadletz, L; Stanisz, I; Brunner, M; Kotowski, U; Enzenhofer, E; Heiduschka, G Assessment of caroverine as a potential chemotherapeutical agent in HNSCC cell lines.
Eur Arch Otorhinolaryngol. 2015; 272(11):3451-3456
Web of Science PubMed FullText FullText_MUG

 

Hilbe, W; Pall, G; Kocher, F; Pircher, A; Zabernigg, A; Schmid, T; Schumacher, M; Jamnig, H; Fiegl, M; Gächter, A; Freund, M; Kendler, D; Manzl, C; Zelger, B; Popper, H; Wöll, E Multicenter Phase II Study Evaluating Two Cycles of Docetaxel, Cisplatin and Cetuximab as Induction Regimen Prior to Surgery in Chemotherapy-Naive Patients with NSCLC Stage IB-IIIA (INN06-Study).
PLoS One. 2015; 10(5):e0125364-e0125364 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kadletz, L; Heiduschka, G; Domayer, J; Schmid, R; Enzenhofer, E; Thurnher, D Evaluation of spheroid head and neck squamous cell carcinoma cell models in comparison to monolayer cultures.
Oncol Lett. 2015; 10(3):1281-1286 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Kotowski, U; Heiduschka, G; Seemann, R; Eckl-Dorna, J; Schmid, R; Kranebitter, V; Stanisz, I; Brunner, M; Lill, C; Thurnher, D Effect of the coffee ingredient cafestol on head and neck squamous cell carcinoma cell lines.
Strahlenther Onkol. 2015; 191(6):511-517
Web of Science PubMed FullText FullText_MUG

 

Mayr, C; Wagner, A; Neureiter, D; Pichler, M; Jakab, M; Illig, R; Berr, F; Kiesslich, T The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.
BMC Complement Altern Med. 2015; 15(6):194-194 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Selzer, E; Grah, A; Heiduschka, G; Kornek, G; Thurnher, D Primary radiotherapy or postoperative radiotherapy in patients with head and neck cancer: Comparative analysis of inflammation-based prognostic scoring systems.
Strahlenther Onkol. 2015; 191(6):486-494
Web of Science PubMed FullText FullText_MUG

 

Stotz, M; Gerger, A; Haybaeck, J; Kiesslich, T; Bullock, MD; Pichler, M Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future.
Anticancer Res. 2015; 35(11):5737-5744
Web of Science PubMed

 

Volgger, B; Zeimet, AG; Reinthaller, A; Petru, E; Schauer, C; Klein, M; Sevelda-Schwarzgruber, U; Bogner, G; Wolfram, G; Marth, C Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO Austria.
Int J Gynecol Cancer. 2015; 25(2):257-262 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2014

Gerber, NU; von Hoff, K; Resch, A; Ottensmeier, H; Kwiecien, R; Faldum, A; Matuschek, C; Hornung, D; Bremer, M; Benesch, M; Pietsch, T; Warmuth-Metz, M; Kuehl, J; Rutkowski, S; Kortmann, RD Treatment of children with central nervous system primitive neuroectodermal tumors/pinealoblastomas in the prospective multicentric trial HIT 2000 using hyperfractionated radiation therapy followed by maintenance chemotherapy.
Int J Radiat Oncol Biol Phys. 2014; 89(4):863-871
Web of Science PubMed FullText FullText_MUG

 

Heiduschka, G; Lill, C; Schneider, S; Seemann, R; Kornek, G; Schmid, R; Kotowski, U; Thurnher, D The effect of cilengitide in combination with irradiation and chemotherapy in head and neck squamous cell carcinoma cell lines.
Strahlenther Onkol. 2014; 190(5): 472-479.
Web of Science PubMed FullText FullText_MUG

 

Heiduschka, G; Lill, C; Seemann, R; Brunner, M; Schmid, R; Houben, R; Bigenzahn, J; Thurnher, D The effect of resveratrol in combination with irradiation and chemotherapy: study using Merkel cell carcinoma cell lines.
Strahlenther Onkol. 2014; 190(1): 75-80.
Web of Science PubMed FullText FullText_MUG

 

Hofmann, H; von Haken, R; Werner, J; Kortes, N; Bergmann, F; Schemmer, P; Jäger, D; Radeleff, B; Schulze-Bergkamen, H Unresectable isolated hepatic metastases from solid pseudopapillary neoplasm of the pancreas: a case report of chemosaturation with high-dose melphalan.
Pancreatology. 2014; 14(6):546-549 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Kiesslich, T; Mayr, C; Wachter, J; Bach, D; Fuereder, J; Wagner, A; Alinger, B; Pichler, M; Di Fazio, P; Ocker, M; Berr, F; Neureiter, D Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer.
Mol Cell Biochem. 2014; 396(1-2):257-268
Web of Science PubMed FullText FullText_MUG

 

Ma, X; Rousseau, V; Sun, H; Lantuejoul, S; Filipits, M; Pirker, R; Popper, H; Mendiboure, J; Vataire, AL; Le Chevalier, T; Soria, JC; Brambilla, E; Dunant, A; Hainaut, P; IALT-Bio working group Significance of TP53 mutations as predictive markers of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer.
Mol Oncol. 2014; 8(3):555-564 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Pircher, A; Gamerith, G; Amann, A; Reinold, S; Popper, H; Gächter, A; Pall, G; Wöll, E; Jamnig, H; Gastl, G; Wolf, AM; Hilbe, W; Wolf, D Neoadjuvant chemo-immunotherapy modifies CD4(+)CD25(+) regulatory T cells (Treg) in non-small cell lung cancer (NSCLC) patients.
Lung Cancer. 2014; 85(1): 81-87.
Web of Science PubMed FullText FullText_MUG

 

Schelch, K; Hoda, MA; Klikovits, T; Münzker, J; Ghanim, B; Wagner, C; Garay, T; Laszlo, V; Setinek, U; Dome, B; Filipits, M; Pirker, C; Heffeter, P; Selzer, E; Tovari, J; Torok, S; Kenessey, I; Holzmann, K; Grasl-Kraupp, B; Marian, B; Klepetko, W; Berger, W; Hegedus, B; Grusch, M Fibroblast growth factor receptor inhibition is active against mesothelioma and synergizes with radio- and chemotherapy.
Am J Respir Crit Care Med. 2014; 190(7):763-772
Web of Science PubMed FullText FullText_MUG

 

2013

Olaussen, KA; Adam, J; Vanhecke, E; Vielh, P; Pirker, R; Friboulet, L; Popper, H; Robin, A; Commo, F; Thomale, J; Kayitalire, L; Filipits, M; Le Chevalier, T; André, F; Brambilla, E; Soria, JC PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Lung Cancer. 2013; 80(2):216-222 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

van Oosterwijk, JG; Meijer, D; van Ruler, MA; van den Akker, BE; Oosting, J; Krenács, T; Picci, P; Flanagan, AM; Liegl-Atzwanger, B; Leithner, A; Athanasou, N; Daugaard, S; Hogendoorn, PC; Bovée, JV Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.
Am J Pathol. 2013; 182(4):1347-1356 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2012

Deutsch, AJ; Angerer, H; Fuchs, TE; Neumeister, P The nuclear orphan receptors NR4A as therapeutic target in cancer therapy.
Anticancer Agents Med Chem. 2012; 12(9):1001-1014
Web of Science PubMed

 

Kotowski, U; Heiduschka, G; Brunner, M; Erovic, BM; Martinek, H; Thurnher, D Arsenic trioxide enhances the cytotoxic effect of cisplatin in head and neck squamous cell carcinoma cell lines.
Oncol Lett. 2012; 3(6):1326-1330 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Lohberger, B; Rinner, B; Stuendl, N; Absenger, M; Liegl-Atzwanger, B; Walzer, SM; Windhager, R; Leithner, A Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.
PLoS One. 2012; 7(8):e43664-e43664 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2011

Lill, C; Kornek, G; Bachtiary, B; Selzer, E; Schopper, C; Mittlboeck, M; Burian, M; Wrba, F; Thurnher, D Survival of patients with HPV-positive oropharyngeal cancer after radiochemotherapy is significantly enhanced.
Wien Klin Wochenschr. 2011; 123(7-8):215-221
Web of Science PubMed FullText FullText_MUG

 

Wohlkoenig, C; Leithner, K; Deutsch, A; Hrzenjak, A; Olschewski, A; Olschewski, H Hypoxia-induced cisplatin resistance is reversible and growth rate independent in lung cancer cells.
Cancer Lett. 2011; 308(2): 134-143.
Web of Science PubMed FullText FullText_MUG

 

2010

Voortman, J; Goto, A; Mendiboure, J; Sohn, JJ; Schetter, AJ; Saito, M; Dunant, A; Pham, TC; Petrini, I; Lee, A; Khan, MA; Hainaut, P; Pignon, JP; Brambilla, E; Popper, HH; Filipits, M; Harris, CC; Giaccone, G MicroRNA Expression and Clinical Outcomes in Patients Treated with Adjuvant Chemotherapy after Complete Resection of Non-Small Cell Lung Carcinoma.
Cancer Res. 2010; 70(21): 8288-8298. [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG Google Scholar

 

Weitere 50 Treffer anzeigen

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum